For instance, BCL7A and GRB10 showed protective roles in some cancers, possibly through mechanisms such as enhancing immune infiltration or suppressing oncogenic pathways, while THEM4, TDRD9, and KLRG1 acted as risk factors in others, potentially by inhibiting tumor suppressor functions. This evidence concerns the gene KLRG1 and cancer.